Phase Forward is a leading provider of integrated data collection and data management solutions for clinical trials and drug safety. The company's award-winning technology and global services are designed to enable life sciences companies of all types and sizes to automate and integrate the management of their entire clinical development process – from study initiation and FDA submission through post-marketing studies. The company's products and services have been used in over 10,000 clinical trials involving more than 1,000,000 trial study participants at over 250 life sciences companies, medical device firms, regulatory agencies and public health organizations.
Phase Forward is a publicly held company (NASDAQ: PFWD) with corporate headquarters in Waltham, Massachusetts, international headquarters in Maidenhead, UK and regional offices in the U.S., Japan, France and Australia.
|
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. The company's proven LogPad and StudyPad Systems improve data quality while the robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials. |
